21 . November , 2017 - Tuesday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Bacitracin Polymyxin B

Big Image
Generic Name: bacitracin zinc and polymyxin B sulfate
Dosage Form: Ophthalmic ointment, usp

STERILE

Rx only

Bacitracin Polymyxin B Description

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment, USP, is a sterile antimicrobial ointment for ophthalmic use. Each gram contains: bacitracin zinc equivalent to 500 bacitracin units, polymyxin B sulfate equivalent to 10,000 polymyxin B units, mineral oil, and white petrolatum.

Bacitracin zinc is the zinc salt of bacitracin, a mixture of related cyclic polypeptides (mainly bacitracin A) produced by the growth of an organism of the licheniformis group of Bacillus subtilis var Tracy. It has a potency of not less than 40 bacitracin units per mg. The structural formula for bacitracin A is:

Polymyxin B sulfate is the sulfate salt of polymyxin B1 and B2 which are produced by the growth of Bacillus polymyxa (Prazmowski) Migula (Fam. Bacillaceae). It has a potency of not less than 6,000 polymyxin B units per mg, calculated on an anhydrous basis. The structural formulae are:

Bacitracin Polymyxin B - Clinical Pharmacology

A wide range of antibacterial action is provided by the overlapping spectra of bacitracin and polymyxin B sulfate.

Bacitracin is bactericidal for a variety of gram-positive and gram-negative organisms. It interferes with bacterial cell wall synthesis by inhibition of the regeneration of phospholipid receptors involved in peptidoglycan synthesis.

Polymyxin B is bactericidal for a variety of gram-negative organisms. It increases the permeability of the bacterial cell membrane by interacting with the phospholipid components of the membrane.

Microbiology: Bacitracin zinc and polymyxin B sulfate together are considered active against the following microorganisms: Staphylococcus aureus, streptococci including Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae, Klebsiella/Enterobacter species, Neisseria species, and Pseudomonas aeruginosa. The product does not provide adequate coverage against Serratia marcescens.

Indications and Usage for Bacitracin Polymyxin B

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. Such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis.

Contraindications

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment is contraindicated in individuals who have shown hypersensitivity to any of its components.

Warnings

NOT FOR INJECTION INTO THE EYE. Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment should never be directly introduced into the anterior chamber of the eye. Ophthalmic ointments may retard corneal wound healing.

Topical antibiotics may cause cutaneous sensitization. A precise incidence of hypersensitivity reactions (primarily skin rash) due to topical antibiotics is not known. The manifestations of sensitization to topical antibiotics are usually itching, reddening, and edema of the conjunctiva and eyelid. A sensitization reaction may manifest simply, as a failure to heal. During long-term use of topical antibiotic products, periodic examination for such signs is advisable, and the patient should be told to discontinue the product if they are observed. Symptoms usually subside quickly on withdrawing the medication. Application of products containing these ingredients should be avoided for the patient thereafter (see PRECAUTIONS: General).

Precautions

General: As with other antibiotic preparations, prolonged use of Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment may result in overgrowth of nonsusceptible organisms including fungi. If superinfection occurs, appropriate measures should be initiated.

Bacterial resistance to Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment may also develop. If purulent discharge, inflammation, or pain become aggravated, the patient should discontinue use of the medication and consult a physician.

There have been reports of bacterial keratitis associated with the use of topical ophthalmic products in multiple-dose containers which have been inadvertently contaminated by patients, most of whom has a concurrent corneal disease or a disruption of the ocular epithelial surface (see PRECAUTIONS: Information for Patients).

Allergic cross-reactions may occur which could prevent the use of any or all of the following antibiotics for the treatment of future infections: kanamycin, paromomycin, streptomycin, and possibly gentamicin.

Information for Patients: Patients should be instructed to avoid allowing the tip of the dispensing container to contact the eye, eyelid, fingers, or any other surface. The use of this product by more than one person may spread infection.

Patients should also be instructed that ocular products, if handled improperly, can become contaminated by common bacteria known to cause ocular infections. Serious damage to the eye and subsequent loss of vision may result from using contaminated products (see PRECAUTIONS: General).

If the condition persists or gets worse, or if a rash or other allergic reaction develops, the patient should be advised to stop use and consult a physician. Do not use this product if you are allergic to any of the listed ingredients.

Keep tightly closed when not in use. Keep out of reach of children.

Carcinogenesis, Mutagenesis, Impairment of Fertility: Long-term studies in animals to evaluate carcinogenic or mutagenic potential have not been conducted with polymyxin B sulfate or bacitracin. Polymyxin B has been reported to impair the motility of equine sperm, but its effects on male or female fertility are unknown. No adverse effects on male or female fertility, litter size, or survival were observed in rabbits given bacitracin zinc 100 gm/ton of diet.

Pregnancy:Teratogenic effects -Pregnancy Category C. Animal reproduction studies have not been conducted with polymyxin B sulfate or bacitracin. It is also not known whether Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment should be given to a pregnant woman only if clearly needed.

Nursing Mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment is administered to a nursing woman.

Pediatric Use: Safety and effectiveness in pediatric patients have not been established.

Adverse Reactions

Adverse reactions have occurred with the anti-infective components of Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment. The exact incidence is not known. Reactions occurring most often are allergic sensitization reactions including itching, swelling, and conjunctival erythema (see WARNINGS). More serious hypersensitivity reactions, including anaphylaxis, have been reported rarely.

Local irritation on instillation has also been reported.

Bacitracin Polymyxin B Dosage and Administration

Apply the ointment every 3 or 4 hours for 7 to 10 days, depending on the severity of the infection.

How is Bacitracin Polymyxin B Supplied

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment, USP, is supplied as follows:

                                NDC 0168 - 0273 - 38                                3.5 gram tubes

Store between 15° and 25°C (59° and 77°F).

E. FOUGERA & CO.

a division of Altana Inc., MELVILLE, NEW YORK 11747

I273
#58
R4/99


Bacitracin Zinc and Polymyxin B Sulfate (Bacitracin zinc and Polymyxin B sulfate)
PRODUCT INFO
Product Code 0168-0273 Dosage Form OINTMENT
Route Of Administration OPHTHALMIC DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
bacitracin zinc (bacitracin) Active 500 UNITS  In 1 GRAM
polymyxin B sulfate (polymyxin B) Active 10000 UNITS  In 1 GRAM
mineral oil Inactive  
white petrolatum Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 0168-0273-38 3.5 GRAM In 1 TUBE None

Revised: 05/2007

Recent Drug Updates at DrugIndexOnline:





Apo-Baclofen Apo-Baclofen
Some commonly used brand names are: In the U.S.— Lioresal In Canada— Lioresal Apo-Baclofen Novo-Baclofen Nu-Baclofen PMS-Baclofen Generic name product may be available in the U.S. Category Antispastic analgesic (in trigeminal neuralgia) Description Baclofen (BAK-loe-fen) more...

Broncomar GG Broncomar GG
Some commonly used brand names are: In the U.S.— Bronchial Broncomar GG Ed-Bron G Elixophyllin-GG Equibron G Glyceryl-T Quibron Quibron-300 Slo-Phyllin GG Theolate Theocon Generic name product may be available in the U.S. Another commonly used name is theophylline and glyceryl guaiacolat more...

Dexasporin Dexasporin
Generic Name: neomycin/polymyxin B and dexamethasone ophthalmic (nee oh MYE sin, paw lee MIX in and dex a METH a sone) Brand Names: AK-Trol, Dexacidin, Dexacine, Dexasporin, Maxitrol, Methadex, Poly-Dex What is Dexasporin (neomycin/polymyxin B and dexamethasone ophthalmic)? Neomycin and more...

Dextrose injection infants Dextrose injection infants
Generic Name: Dextrose monohydrate Dosage Form: Injection infants Rx only CONCENTRATED Dextrose FOR INTRAVENOUS ADMINISTRATION TO INFANTS. NOTE: This solution is hypertonic— see Warnings and Precautions. Plastic Syringe Dextrose Description 25% Dextrose Injection, USP is a sterile, nonpyr more...

Hydrocodone Bitartrate and Acetaminophen Oral Solution Hydrocodone Bitartrate and Acetaminophen Oral Solution
Dosage Form: Oral solution Rx ONLY Hydrocodone Bitartrate and Acetaminophen Description Hydrocodone Bitartrate and Acetaminophen is supplied in liquid form for oral administration. Warning: May be habit forming (see PRECAUTIONS, Information for Patients, and DRUG ABUSE AND DEPENDENCE) more...

Methdilazine Methdilazine
Note: Products containing trimeprazine were withdrawn from the market by Allergan in July 1999 Some commonly used brand names are: In the U.S.— Anergan 25 2 Anergan 50 2 Antinaus 50 2 Pentazine 2 Phenazine 25 2 Phenazine 50 2 Phencen-50 2 Phenergan 2 Phenergan Fortis 2 Phenergan P more...

Plan B Plan B
Generic Name: Levonorgestrel Tablets (LEE-voe-nor-JESS-truhl) Brand Name: Plan BPlan B is used for:Preventing pregnancy after unprotected sexual intercourse or suspected birth control failure. Plan B is a progestin. How it works is not fully known. It may prevent pregnancy by inhibiting ovulat more...

Predalone 50 Predalone 50
Some commonly used brand names are: In the U.S.— Acetocot 9 A-hydroCort 5 Amcort 9 A-MethaPred 6 Aristocort 9 Aristocort Forte 9 Aristopak 9 Aristospan 9 Articulose-50 7 Articulose-L.A. 9 Celestone 1 Celestone Phosphate 1 Celestone Soluspan 1 Cinalone 40 9 Cinonide 40 9 Clinacort 9 Clinal more...